An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
Researchers have known that microorganisms in the gut can impact the effectiveness of immunogenic chemotherapies for cancer patients. When studies showed that the same could be true for immune checkpoint inhibitors, it opened the possibility for better treatment options for…
UPMC Hillman Cancer Center is pleased to announce Patricia L. Opresko, PhD, as the Dr. Bernard F. Fisher Chair for Breast Cancer Discovery Science, a newly formed chair being launched this year. Dr. Opresko was nominated for this appointment because…
Head and neck cancer accounts for approximately 4% of cancer cases in the U.S. — affecting more than 60,000 people each year. The majority of those diagnosed are over the age of 50, but a rising rate of HPV-associated head…
Friday, April 14 Sessions Nadine Hempel, PhD “Oxidative stress adaptations during metastasis: Focus on antioxidant enzyme function and regulation” 3 to 4:30 p.m. Tangerine Ballroom 3 & 4 Lan G. Coffman, MD, PhD “Studying the impact of the aging stromal…
This month, women’s history was celebrated bringing attention to the remarkable role that women play in society. Here at UPMC Hillman Cancer Center, our Women’s Initiatives Task Force supports and fosters women all throughout the year. They kicked off 2023…
For Women’s History Month, this research Q&A focuses on Kelly Bailey, MD, PhD, and her experience as a female researcher. Dr. Kelly Bailey is a member of the Cancer Biology Program at UPMC Hillman Cancer Center, assistant professor in the…
UPMC Hillman Cancer Center is very pleased to announce Diwakar Davar, MD, MS, as clinical director for the Melanoma and Skin Cancer Program at UPMC Hillman, effective March 1, 2023. Dr. Davar is a medical oncologist and hematologist at UPMC…
For Women’s History Month, this research Q&A focuses on Olivera Finn, PhD, and her experience as a female researcher. Dr. Finn is a member of the Cancer Immunology and Immunotherapy Program at UPMC Hillman Cancer Center and distinguished professor in…
According to the American Medical Association, racial and ethnic minorities experience a lower quality of health care, are less likely to receive routine care, and face higher rates of morbidity and mortality than nonminorities. When it comes to cancer patients,…
UPMC Hillman Cancer Center is pleased to welcome Renfeng Li, PhD. Dr. Li joined January 1, 2023 and is associate professor of Microbiology and Molecular Genetics and a member of the Cancer Virology research program at UPMC Hillman. His research…
